Cellebrite DI Ltd. (CLBT) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — CLBT

Balance Sheet

(in millions USD)

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Cash & Equivalents	179.22	106.96	110.50	91.69
Short-term Investments	146.91	71.63	57.61	32.44
Accounts Receivable	93.13	0.13	0.11	66.75
Inventory	9.54	8.78	10.82	8.12
Total Current Assets	606.11	414.75	337.41	233.64
Property, Plant & Equipment	19.96	15.81	15.81	17.77
Goodwill	28.71	26.83	26.83	26.83
Intangible Assets	10.24	9.81	9.62	17.95
Total Non-current Assets	181.32	141.83	88.49	91.20
Total Assets	787.43	556.58	425.89	324.84
Accounts Payable	--	42.26	35.62	47.45
Total Current Liabilities	309.97	237.23	204.51	172.87
Total Non-current Liabilities	69.04	359.51	203.83	127.91
Total Liabilities	379.01	596.74	408.34	300.78
Retained Earnings	(127.99)	22.96	126.29	167.07
Total Stockholder Equity	408.41	(40.16)	17.56	24.06

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Total Revenue	220.83	2.45	97.88	70.39
Cost of Revenue	35.17	29.53	25.44	24.08
Gross Profit	185.66	155.77	122.48	100.88
Research & Development	55.89	46.89	42.18	39.25
Selling, General & Admin	25.63	22.77	21.19	21.02
Total Operating Expenses	158.97	134.04	117.72	108.42
Operating Income	26.69	21.73	4.76	(7.54)
Pretax Income	40.12	(91.34)	(70.07)	87.32
Tax Provision	3.24	3.84	2.89	(1.31)
Net Income	36.88	(95.18)	(72.95)	88.64
Basic EPS	0.15	(0.48)	(0.37)	0.47
Diluted EPS	0.15	(0.48)	(0.37)	0.44

Cash Flow Statement

(in millions USD)

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Operating Cash Flow	53.46	24.55	29.05	(14.61)
Capital Expenditures	5.95	3.57	1.89	3.88
Free Cash Flow*	47.51	20.99	27.16	(18.49)
Investing Cash Flow	(85.93)	(114.86)	(14.81)	(41.99)
Financing Cash Flow	17.45	8.39	8.42	4.69

* Derived from reported values